Welcome
Support Centre
13 October 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Efficacy of EPs 7630 in acute non-streptococcal tonsillopharyngitis
ISRCTN ISRCTN03930168
ClinicalTrials.gov identifier
Public title Efficacy of EPs 7630 in acute non-streptococcal tonsillopharyngitis
Scientific title
Acronym N/A
Serial number at source UM002
Study hypothesis This study was a prospective, monocentre, randomised, open clinical pilot trial, comparing the efficacy of the herbal medicine EPs 7630 versus symptomatic therapy in patients with acute, non-streptococcal tonsillopharyngitis.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Acute, non-streptococcal tonsillopharyngitis
Participants - inclusion criteria The study took place between March and April 1997. It is terminated. Patients, who met the following inclusion criteria, were suitable for the trial:
1. Age 6-10 years
2. Acute exsudative tonsillopharyngitis
3. Duration of symptoms less than 48 h
4. No Group A Beta Hemolytic Streptococcus (GABHS)-infection
5. Tonsillopharyngitis Severity Score (TSS) 6 or more points, and
6. Informed consent in writing by legal guardians who were able to understand the nature, meaning and consequences of the trial
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/03/1997
Anticipated end date 30/04/1997
Status of trial Completed
Patient information material
Target number of participants 60
Interventions 60 patients were randomised to receive either:
1. Herbal remedy EPs 7630, 20 drops thrice daily, or
2. Symptomatic therapy (gargling with fruit vinegar and lukewarm water, Priessnitz compresses).

The duration of individual treatment lasted over a maximum of 10 days.
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding ISO Arzneimittel GmbH & Co KG
Trial website
Publications
Contact name Dr  Marianne  Heger
  Address Director Research Center HomInt
PO Box 41 02 40
  City/town Karlsruhe
  Zip/Postcode 76202
  Country Germany
Sponsor ISO Arzneimittel GmbH & Co KG (Germany)
  Address Bunsenstrasse 6-10
  City/town Ettlingen
  Zip/Postcode 76275
  Country Germany
  Sponsor website: http://www.iso-arznei.de
Date applied 14/06/2002
Last edited 02/10/2007
Date ISRCTN assigned 14/06/2002
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central